Bridgepoint Group (LON:BPT) Stock Rating Reaffirmed as “Buy” by Jefferies Financial Group

Bridgepoint Group (LON:BPT)‘s stock had its “buy” rating restated by equities research analysts at Jefferies Financial Group in a research report issued on Thursday, Digital Look reports. They presently have a GBX 485 price target on the stock. Jefferies Financial Group’s price target suggests a potential upside of 19.46% from the stock’s previous close.

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 360 target price on shares of Bridgepoint Group in a research report on Friday, September 18th. Four investment analysts have rated the stock with a Buy rating. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of GBX 413.75.

Bridgepoint Group Price Performance

BPT traded down GBX 6 on Thursday, hitting GBX 406. 2,373,991 shares of the stock were exchanged, compared to its average volume of 7,565,838. Bridgepoint Group has a 12 month low of GBX 212 and a 12 month high of GBX 416.20. The business has a 50-day moving average of GBX 324.30 and a two-hundred day moving average of GBX 286.80. The company has a debt-to-equity ratio of 53.71, a current ratio of 16.31 and a quick ratio of 3.60. The firm has a market capitalization of £3.66 billion, a price-to-earnings ratio of 135.33, a PEG ratio of 0.61 and a beta of 1.39.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.